Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus

Journal of Internal Medicine

Volumn 276, Issue 2, 2014, Pages 174-183

  Engstrom G ^a   Smith, J G ^a   Persson, M ^a   Nilsson, P M ^a   Melander, O ^a   Hedblad, B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Diabetes; Epidemiology; Erythrocytes; Glucose; HbA1c

Indexed keywords

GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; ERYTHROCYTE; ERYTHROCYTE VOLUME; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; HAZARD RATIO; HUMAN; HYPERGLYCEMIA; INCIDENCE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

DIABETES; EPIDEMIOLOGY; ERYTHROCYTES; GLUCOSE; HBA1C;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS; ERYTHROCYTE COUNT; ERYTHROCYTE INDICES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWEDEN; WAIST CIRCUMFERENCE;

EID: 84904313678     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12188     Document Type: Article

References (41)

1. Montagnana M, Cervellin G, Meschi T, Lippi G. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 2011; 50: 635-641.
2. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009; 169: 588-594.
3. Borné Y, Smith JG, Melander O, Hedblad B, Engström G. Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study. Eur J Heart Fail 2011; 13: 1355-1361.
4. Eryd SA, Borné Y, Melander O et al. Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med 2014; 275: 84-92.
5. Felker GM, Allen LA, Pocock SJ et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: 40-47.
6. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M; for the CARE Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117:163-168.
7. Ozcan F, Turak O, Avci S et al. Heart rate variability and red cell distribution width in patients with systolic left heart failure. Scand Cardiovasc J 2013; 47: 225-229.
8. Tsuboi S, Miyauchi K, Kasai T et al. Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention. Circ J 2013; 77: 456-461.
9. Malandrino N, Wu WC, Taveira TH, Whitlatch HB, Smith RJ. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia 2012; 55: 226-235.
10. Horne BD. A changing focus on the red cell distribution width: why does it predict mortality and other adverse medical outcomes? Cardiology 2012; 122: 213-215.
11. Veeranna V, Zalawadiya SK, Panaich SS, Ramesh K, Afonso L. The association of red cell distribution width with glycated hemoglobin among healthy adults without diabetes mellitus. Cardiology 2012; 122: 129-132.
12. Simmons D. Increased red cell count in diabetes and pre-diabetes. Diabetes Res Clin Pract 2010; 90: e50-e53.
13. Singh DK, Winocour P, Farrington K. Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol 2009; 5: 204-210.
14. Singh M, Shin S. Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review. Indian J Exp Biol 2009; 47: 7-15.
15. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004; 27: 931-935.
16. Venerando B, Fiorilli A, Croci G et al. Acidic and neutral sialidase in the erythrocyte membrane of type 2 diabetic patients. Blood 2002; 99: 1064-1070.
17. Peterson CM, Jones RL, Koenig RJ, Melvin ET, Lehrman ML. Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med 1977; 86: 425-429.
18. Hedblad B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med 2000; 17: 299-307.
19. Melander O, Maisel AS, Almgren P et al. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA 2012; 308: 1469-1475.
20. Wirfält E, Mattisson I, Johansson U, Gullberg B, Wallström P, Berglund G. A methodological report from the Malmö Diet and Cancer study: development and evaluation of altered routines in dietary data processing. Nutr J 2002; 1: 3.
21. Ericson U, Sonestedt E, Gullberg B, Olsson H, Wirfält E. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort. Am J Clin Nutr 2007; 86: 434-443.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
23. Enhörning S, Wang TJ, Nilsson PM et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 2010; 121: 2102-2108.
24. Fava C, Sjögren M, Montagnana M et al. Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in swedes. Hypertension 2013; 61: 319-326.
25. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
26. Hassan Y, Johnson B, Nader N, Gannon MC, Nuttall FQ. The relationship between 24-hour integrated glucose concentrations and% glycohemoglobin. J Lab Clin Med 2006; 147: 21-26.
27. Kilpatrick ES, Rigby AS, Atkin SL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem 2007; 53: 897-901.
28. Cohen RM, Franco RS, Khera PK et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008; 112: 4284-4291.
29. Higgins T. HbA1c - An analyte of increasing importance. Clin Biochem 2012; 45: 1038-1045.
30. Franco RS, Puchulu-Campanella ME, Barber LA et al. Changes in the properties of normal human red blood cells during in vivo aging. Am J Hematol 2013; 88: 44-51.
31. Mohandas N, Groner W. Cell membrane and volume changes during red cell development and aging. Ann N Y Acad Sci 1989; 554: 217-224.
32. Gifford SC, Derganc J, Shevkoplyas SS, Yoshida T, Bitensky MW. A detailed study of time-dependent changes in human red blood cells: from reticulocyte maturation to erythrocyte senescence. Br J Haematol 2006; 135: 395-404.
33. Waugh RE, Narla M, Jackson CW, Mueller TJ, Suzuki T, Dale GL. Rheologic properties of senescent erythrocytes: loss of surface area and volume with red blood cell age. Blood 1992; 79: 1351-1358.
34. Furne JK, Springfield JR, Ho SB, Levitt MD. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 2003; 142: 52-57.
35. Grossin N, Wautier MP, Wautier JL. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology 2009; 46: 63-72.
36. Kowluru R, Bitensky MW, Kowluru A, Dembo M, Keaton PA, Buican T. Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy. Proc Natl Acad Sci USA 1989; 86: 3327-3331.
37. Cohen RM, Franco RS, Joiner CH. Is poor glycemic control associated with reduced red blood cell lifespan? Diabetes Care 2004; 27: 1013-1014.
38. Mitchell RM, Robinson TJ. Monitoring dietary compliance in coeliac disease using red cell distribution width. Int J Clin Pract 2002; 56: 249-250.
39. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009; 158: 659-666.
40. Duncan BB, Schmidt MI. The epidemiology of low-grade chronic systemic inflammation and Type 2 diabetes. Diabetes Technol Ther 2006; 8: 7-17.
41. Maes M, Scharpé S, Cooreman W et al. Components of biological, including seasonal, variation in hematological measurements and plasma fibrinogen concentrations in normal humans. Experientia 1995; 51: 141-149.